Table of Content

1 Study Coverage
1.1 Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Product Introduction
1.2 Market by Type
1.2.1 Global Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Market Size Growth Rate by Type, 2018 VS 2022 VS 2029
1.2.2 DTaP
1.2.3 Tdap
1.3 Market by Application
1.3.1 Global Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Market Size Growth Rate by Application, 2018 VS 2022 VS 2029
1.3.2 Child
1.3.3 Adult
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Sales Estimates and Forecasts 2018-2029
2.2 Global Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Revenue by Region
2.2.1 Global Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Revenue by Region: 2018 VS 2022 VS 2029
2.2.2 Global Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Revenue by Region (2018-2024)
2.2.3 Global Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Revenue by Region (2024-2029)
2.2.4 Global Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Revenue Market Share by Region (2018-2029)
2.3 Global Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Sales Estimates and Forecasts 2018-2029
2.4 Global Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Sales by Region
2.4.1 Global Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Sales by Region: 2018 VS 2022 VS 2029
2.4.2 Global Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Sales by Region (2018-2024)
2.4.3 Global Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Sales by Region (2024-2029)
2.4.4 Global Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Sales Market Share by Region (2018-2029)
2.5 US & Canada
2.6 Europe
2.7 China
2.8 Asia (excluding China)
2.9 Middle East, Africa and Latin America
3 Competition by Manufactures
3.1 Global Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Sales by Manufacturers
3.1.1 Global Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Sales by Manufacturers (2018-2024)
3.1.2 Global Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Sales Market Share by Manufacturers (2018-2024)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine in 2022
3.2 Global Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Revenue by Manufacturers
3.2.1 Global Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Revenue by Manufacturers (2018-2024)
3.2.2 Global Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Revenue Market Share by Manufacturers (2018-2024)
3.2.3 Global Top 10 and Top 5 Companies by Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Revenue in 2022
3.3 Global Key Players of Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine, Industry Ranking, 2021 VS 2022 VS 2024
3.4 Global Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Sales Price by Manufacturers
3.5 Analysis of Competitive Landscape
3.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.5.2 Global Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Key Manufacturers of Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine, Manufacturing Base Distribution and Headquarters
3.7 Global Key Manufacturers of Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine, Product Offered and Application
3.8 Global Key Manufacturers of Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine, Date of Enter into This Industry
3.9 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Sales by Type
4.1.1 Global Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Historical Sales by Type (2018-2024)
4.1.2 Global Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Forecasted Sales by Type (2024-2029)
4.1.3 Global Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Sales Market Share by Type (2018-2029)
4.2 Global Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Revenue by Type
4.2.1 Global Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Historical Revenue by Type (2018-2024)
4.2.2 Global Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Forecasted Revenue by Type (2024-2029)
4.2.3 Global Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Revenue Market Share by Type (2018-2029)
4.3 Global Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Price by Type
4.3.1 Global Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Price by Type (2018-2024)
4.3.2 Global Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Price Forecast by Type (2024-2029)
5 Market Size by Application
5.1 Global Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Sales by Application
5.1.1 Global Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Historical Sales by Application (2018-2024)
5.1.2 Global Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Forecasted Sales by Application (2024-2029)
5.1.3 Global Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Sales Market Share by Application (2018-2029)
5.2 Global Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Revenue by Application
5.2.1 Global Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Historical Revenue by Application (2018-2024)
5.2.2 Global Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Forecasted Revenue by Application (2024-2029)
5.2.3 Global Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Revenue Market Share by Application (2018-2029)
5.3 Global Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Price by Application
5.3.1 Global Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Price by Application (2018-2024)
5.3.2 Global Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Price Forecast by Application (2024-2029)
6 US & Canada
6.1 US & Canada Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Market Size by Type
6.1.1 US & Canada Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Sales by Type (2018-2029)
6.1.2 US & Canada Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Revenue by Type (2018-2029)
6.2 US & Canada Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Market Size by Application
6.2.1 US & Canada Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Sales by Application (2018-2029)
6.2.2 US & Canada Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Revenue by Application (2018-2029)
6.3 US & Canada Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Market Size by Country
6.3.1 US & Canada Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Revenue by Country: 2018 VS 2022 VS 2029
6.3.2 US & Canada Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Sales by Country (2018-2029)
6.3.3 US & Canada Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Revenue by Country (2018-2029)
6.3.4 US
6.3.5 Canada
7 Europe
7.1 Europe Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Market Size by Type
7.1.1 Europe Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Sales by Type (2018-2029)
7.1.2 Europe Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Revenue by Type (2018-2029)
7.2 Europe Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Market Size by Application
7.2.1 Europe Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Sales by Application (2018-2029)
7.2.2 Europe Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Revenue by Application (2018-2029)
7.3 Europe Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Market Size by Country
7.3.1 Europe Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Revenue by Country: 2018 VS 2022 VS 2029
7.3.2 Europe Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Sales by Country (2018-2029)
7.3.3 Europe Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Revenue by Country (2018-2029)
7.3.4 Germany
7.3.5 France
7.3.6 UK
7.3.7 Italy
7.3.8 Russia
8 China
8.1 China Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Market Size
8.1.1 China Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Sales (2018-2029)
8.1.2 China Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Revenue (2018-2029)
8.2 China Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Market Size by Application
8.2.1 China Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Sales by Application (2018-2029)
8.2.2 China Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Revenue by Application (2018-2029)
9 Asia (excluding China)
9.1 Asia Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Market Size by Type
9.1.1 Asia Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Sales by Type (2018-2029)
9.1.2 Asia Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Revenue by Type (2018-2029)
9.2 Asia Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Market Size by Application
9.2.1 Asia Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Sales by Application (2018-2029)
9.2.2 Asia Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Revenue by Application (2018-2029)
9.3 Asia Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Sales by Region
9.3.1 Asia Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Revenue by Region: 2018 VS 2022 VS 2029
9.3.2 Asia Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Revenue by Region (2018-2029)
9.3.3 Asia Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Sales by Region (2018-2029)
9.3.4 Japan
9.3.5 South Korea
9.3.6 China Taiwan
9.3.7 Southeast Asia
9.3.8 India
10 Middle East, Africa and Latin America
10.1 Middle East, Africa and Latin America Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Market Size by Type
10.1.1 Middle East, Africa and Latin America Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Sales by Type (2018-2029)
10.1.2 Middle East, Africa and Latin America Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Revenue by Type (2018-2029)
10.2 Middle East, Africa and Latin America Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Market Size by Application
10.2.1 Middle East, Africa and Latin America Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Sales by Application (2018-2029)
10.2.2 Middle East, Africa and Latin America Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Revenue by Application (2018-2029)
10.3 Middle East, Africa and Latin America Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Sales by Country
10.3.1 Middle East, Africa and Latin America Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Revenue by Country: 2018 VS 2022 VS 2029
10.3.2 Middle East, Africa and Latin America Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Revenue by Country (2018-2029)
10.3.3 Middle East, Africa and Latin America Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Sales by Country (2018-2029)
10.3.4 Brazil
10.3.5 Mexico
10.3.6 Turkey
10.3.7 Israel
10.3.8 GCC Countries
11 Company Profiles
11.1 Sanofi
11.1.1 Sanofi Company Information
11.1.2 Sanofi Overview
11.1.3 Sanofi Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Sales, Price, Revenue and Gross Margin (2018-2024)
11.1.4 Sanofi Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Sanofi Recent Developments
11.2 GSK
11.2.1 GSK Company Information
11.2.2 GSK Overview
11.2.3 GSK Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Sales, Price, Revenue and Gross Margin (2018-2024)
11.2.4 GSK Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 GSK Recent Developments
11.3 KM Biologics
11.3.1 KM Biologics Company Information
11.3.2 KM Biologics Overview
11.3.3 KM Biologics Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Sales, Price, Revenue and Gross Margin (2018-2024)
11.3.4 KM Biologics Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 KM Biologics Recent Developments
11.4 Serum Institute of India
11.4.1 Serum Institute of India Company Information
11.4.2 Serum Institute of India Overview
11.4.3 Serum Institute of India Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Sales, Price, Revenue and Gross Margin (2018-2024)
11.4.4 Serum Institute of India Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Serum Institute of India Recent Developments
11.5 Walvax Biotechnology
11.5.1 Walvax Biotechnology Company Information
11.5.2 Walvax Biotechnology Overview
11.5.3 Walvax Biotechnology Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Sales, Price, Revenue and Gross Margin (2018-2024)
11.5.4 Walvax Biotechnology Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Walvax Biotechnology Recent Developments
11.6 Sinopharm
11.6.1 Sinopharm Company Information
11.6.2 Sinopharm Overview
11.6.3 Sinopharm Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Sales, Price, Revenue and Gross Margin (2018-2024)
11.6.4 Sinopharm Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 Sinopharm Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Industry Chain Analysis
12.2 Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Production Mode & Process
12.4 Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Sales and Marketing
12.4.1 Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Sales Channels
12.4.2 Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Distributors
12.5 Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Customers
13 Market Dynamics
13.1 Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Industry Trends
13.2 Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Market Drivers
13.3 Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Market Challenges
13.4 Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Market Restraints
14 Key Findings in The Global Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer

List of Figure

List of Tables
Table 1. Global Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)
Table 2. Major Manufacturers of DTaP
Table 3. Major Manufacturers of Tdap
Table 4. Global Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)
Table 5. Global Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Revenue Grow Rate (CAGR) by Region: 2018 VS 2022 VS 2029 (US$ Million)
Table 6. Global Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Revenue by Region (2018-2024) & (US$ Million)
Table 7. Global Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Revenue by Region (2024-2029) & (US$ Million)
Table 8. Global Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Revenue Market Share by Region (2018-2024)
Table 9. Global Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Revenue Market Share by Region (2024-2029)
Table 10. Global Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Sales Grow Rate (CAGR) by Region: 2018 VS 2022 VS 2029 (US$ Million)
Table 11. Global Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Sales by Region (2018-2024) & (K Units)
Table 12. Global Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Sales by Region (2024-2029) & (K Units)
Table 13. Global Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Sales Market Share by Region (2018-2024)
Table 14. Global Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Sales Market Share by Region (2024-2029)
Table 15. Global Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Sales by Manufacturers (2018-2024) & (K Units)
Table 16. Global Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Sales Share by Manufacturers (2018-2024)
Table 17. Global Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Revenue by Manufacturers (2018-2024) & (US$ Million)
Table 18. Global Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Revenue Share by Manufacturers (2018-2024)
Table 19. Global Key Players of Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine, Industry Ranking, 2021 VS 2022 VS 2024
Table 20. Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Price by Manufacturers 2018-2024 (USD/Unit)
Table 21. Global Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 22. Global Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine as of 2022)
Table 23. Global Key Manufacturers of Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine, Manufacturing Base Distribution and Headquarters
Table 24. Global Key Manufacturers of Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine, Product Offered and Application
Table 25. Global Key Manufacturers of Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine, Date of Enter into This Industry
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. Global Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Sales by Type (2018-2024) & (K Units)
Table 28. Global Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Sales by Type (2024-2029) & (K Units)
Table 29. Global Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Sales Share by Type (2018-2024)
Table 30. Global Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Sales Share by Type (2024-2029)
Table 31. Global Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Revenue by Type (2018-2024) & (US$ Million)
Table 32. Global Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Revenue by Type (2024-2029) & (US$ Million)
Table 33. Global Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Revenue Share by Type (2018-2024)
Table 34. Global Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Revenue Share by Type (2024-2029)
Table 35. Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Price by Type (2018-2024) & (USD/Unit)
Table 36. Global Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Price Forecast by Type (2024-2029) & (USD/Unit)
Table 37. Global Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Sales by Application (2018-2024) & (K Units)
Table 38. Global Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Sales by Application (2024-2029) & (K Units)
Table 39. Global Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Sales Share by Application (2018-2024)
Table 40. Global Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Sales Share by Application (2024-2029)
Table 41. Global Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Revenue by Application (2018-2024) & (US$ Million)
Table 42. Global Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Revenue by Application (2024-2029) & (US$ Million)
Table 43. Global Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Revenue Share by Application (2018-2024)
Table 44. Global Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Revenue Share by Application (2024-2029)
Table 45. Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Price by Application (2018-2024) & (USD/Unit)
Table 46. Global Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Price Forecast by Application (2024-2029) & (USD/Unit)
Table 47. US & Canada Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Sales by Type (2018-2024) & (K Units)
Table 48. US & Canada Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Sales by Type (2024-2029) & (K Units)
Table 49. US & Canada Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Revenue by Type (2018-2024) & (US$ Million)
Table 50. US & Canada Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Revenue by Type (2024-2029) & (US$ Million)
Table 51. US & Canada Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Sales by Application (2018-2024) & (K Units)
Table 52. US & Canada Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Sales by Application (2024-2029) & (K Units)
Table 53. US & Canada Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Revenue by Application (2018-2024) & (US$ Million)
Table 54. US & Canada Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Revenue by Application (2024-2029) & (US$ Million)
Table 55. US & Canada Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 56. US & Canada Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Revenue by Country (2018-2024) & (US$ Million)
Table 57. US & Canada Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Revenue by Country (2024-2029) & (US$ Million)
Table 58. US & Canada Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Sales by Country (2018-2024) & (K Units)
Table 59. US & Canada Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Sales by Country (2024-2029) & (K Units)
Table 60. Europe Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Sales by Type (2018-2024) & (K Units)
Table 61. Europe Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Sales by Type (2024-2029) & (K Units)
Table 62. Europe Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Revenue by Type (2018-2024) & (US$ Million)
Table 63. Europe Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Revenue by Type (2024-2029) & (US$ Million)
Table 64. Europe Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Sales by Application (2018-2024) & (K Units)
Table 65. Europe Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Sales by Application (2024-2029) & (K Units)
Table 66. Europe Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Revenue by Application (2018-2024) & (US$ Million)
Table 67. Europe Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Revenue by Application (2024-2029) & (US$ Million)
Table 68. Europe Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 69. Europe Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Revenue by Country (2018-2024) & (US$ Million)
Table 70. Europe Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Revenue by Country (2024-2029) & (US$ Million)
Table 71. Europe Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Sales by Country (2018-2024) & (K Units)
Table 72. Europe Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Sales by Country (2024-2029) & (K Units)
Table 73. China Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Sales by Type (2018-2024) & (K Units)
Table 74. China Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Sales by Type (2024-2029) & (K Units)
Table 75. China Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Revenue by Type (2018-2024) & (US$ Million)
Table 76. China Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Revenue by Type (2024-2029) & (US$ Million)
Table 77. China Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Sales by Application (2018-2024) & (K Units)
Table 78. China Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Sales by Application (2024-2029) & (K Units)
Table 79. China Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Revenue by Application (2018-2024) & (US$ Million)
Table 80. China Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Revenue by Application (2024-2029) & (US$ Million)
Table 81. Asia Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Sales by Type (2018-2024) & (K Units)
Table 82. Asia Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Sales by Type (2024-2029) & (K Units)
Table 83. Asia Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Revenue by Type (2018-2024) & (US$ Million)
Table 84. Asia Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Revenue by Type (2024-2029) & (US$ Million)
Table 85. Asia Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Sales by Application (2018-2024) & (K Units)
Table 86. Asia Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Sales by Application (2024-2029) & (K Units)
Table 87. Asia Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Revenue by Application (2018-2024) & (US$ Million)
Table 88. Asia Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Revenue by Application (2024-2029) & (US$ Million)
Table 89. Asia Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 90. Asia Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Revenue by Region (2018-2024) & (US$ Million)
Table 91. Asia Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Revenue by Region (2024-2029) & (US$ Million)
Table 92. Asia Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Sales by Region (2018-2024) & (K Units)
Table 93. Asia Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Sales by Region (2024-2029) & (K Units)
Table 94. Middle East, Africa and Latin America Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Sales by Type (2018-2024) & (K Units)
Table 95. Middle East, Africa and Latin America Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Sales by Type (2024-2029) & (K Units)
Table 96. Middle East, Africa and Latin America Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Revenue by Type (2018-2024) & (US$ Million)
Table 97. Middle East, Africa and Latin America Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Revenue by Type (2024-2029) & (US$ Million)
Table 98. Middle East, Africa and Latin America Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Sales by Application (2018-2024) & (K Units)
Table 99. Middle East, Africa and Latin America Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Sales by Application (2024-2029) & (K Units)
Table 100. Middle East, Africa and Latin America Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Revenue by Application (2018-2024) & (US$ Million)
Table 101. Middle East, Africa and Latin America Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Revenue by Application (2024-2029) & (US$ Million)
Table 102. Middle East, Africa and Latin America Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 103. Middle East, Africa and Latin America Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Revenue by Country (2018-2024) & (US$ Million)
Table 104. Middle East, Africa and Latin America Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Revenue by Country (2024-2029) & (US$ Million)
Table 105. Middle East, Africa and Latin America Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Sales by Country (2018-2024) & (K Units)
Table 106. Middle East, Africa and Latin America Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Sales by Country (2024-2029) & (K Units)
Table 107. Sanofi Company Information
Table 108. Sanofi Description and Major Businesses
Table 109. Sanofi Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 110. Sanofi Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
Table 111. Sanofi Recent Developments
Table 112. GSK Company Information
Table 113. GSK Description and Major Businesses
Table 114. GSK Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 115. GSK Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
Table 116. GSK Recent Developments
Table 117. KM Biologics Company Information
Table 118. KM Biologics Description and Major Businesses
Table 119. KM Biologics Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 120. KM Biologics Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
Table 121. KM Biologics Recent Developments
Table 122. Serum Institute of India Company Information
Table 123. Serum Institute of India Description and Major Businesses
Table 124. Serum Institute of India Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 125. Serum Institute of India Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
Table 126. Serum Institute of India Recent Developments
Table 127. Walvax Biotechnology Company Information
Table 128. Walvax Biotechnology Description and Major Businesses
Table 129. Walvax Biotechnology Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 130. Walvax Biotechnology Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
Table 131. Walvax Biotechnology Recent Developments
Table 132. Sinopharm Company Information
Table 133. Sinopharm Description and Major Businesses
Table 134. Sinopharm Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 135. Sinopharm Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
Table 136. Sinopharm Recent Developments
Table 137. Key Raw Materials Lists
Table 138. Raw Materials Key Suppliers Lists
Table 139. Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Distributors List
Table 140. Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Customers List
Table 141. Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Market Trends
Table 142. Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Market Drivers
Table 143. Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Market Challenges
Table 144. Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Market Restraints
Table 145. Research Programs/Design for This Report
Table 146. Key Data Information from Secondary Sources
Table 147. Key Data Information from Primary Sources
List of Figures
Figure 1. Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Product Picture
Figure 2. Global Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)
Figure 3. Global Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Market Share by Type in 2022 & 2029
Figure 4. DTaP Product Picture
Figure 5. Tdap Product Picture
Figure 6. Global Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)
Figure 7. Global Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Market Share by Application in 2022 & 2029
Figure 8. Child
Figure 9. Adult
Figure 10. Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Report Years Considered
Figure 11. Global Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Revenue, (US$ Million), 2018 VS 2022 VS 2029
Figure 12. Global Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Revenue 2018-2029 (US$ Million)
Figure 13. Global Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Revenue Market Share by Region in Percentage: 2022 Versus 2029
Figure 14. Global Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Revenue Market Share by Region (2018-2029)
Figure 15. Global Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Sales 2018-2029 ((K Units)
Figure 16. Global Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Sales Market Share by Region (2018-2029)
Figure 17. US & Canada Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Sales YoY (2018-2029) & (K Units)
Figure 18. US & Canada Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Revenue YoY (2018-2029) & (US$ Million)
Figure 19. Europe Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Sales YoY (2018-2029) & (K Units)
Figure 20. Europe Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Revenue YoY (2018-2029) & (US$ Million)
Figure 21. China Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Sales YoY (2018-2029) & (K Units)
Figure 22. China Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Revenue YoY (2018-2029) & (US$ Million)
Figure 23. Asia (excluding China) Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Sales YoY (2018-2029) & (K Units)
Figure 24. Asia (excluding China) Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Revenue YoY (2018-2029) & (US$ Million)
Figure 25. Middle East, Africa and Latin America Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Sales YoY (2018-2029) & (K Units)
Figure 26. Middle East, Africa and Latin America Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Revenue YoY (2018-2029) & (US$ Million)
Figure 27. The Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2022
Figure 28. The Top 5 and 10 Largest Manufacturers of Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine in the World: Market Share by Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Revenue in 2022
Figure 29. Global Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022
Figure 30. Global Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Sales Market Share by Type (2018-2029)
Figure 31. Global Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Revenue Market Share by Type (2018-2029)
Figure 32. Global Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Sales Market Share by Application (2018-2029)
Figure 33. Global Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Revenue Market Share by Application (2018-2029)
Figure 34. US & Canada Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Sales Market Share by Type (2018-2029)
Figure 35. US & Canada Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Revenue Market Share by Type (2018-2029)
Figure 36. US & Canada Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Sales Market Share by Application (2018-2029)
Figure 37. US & Canada Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Revenue Market Share by Application (2018-2029)
Figure 38. US & Canada Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Revenue Share by Country (2018-2029)
Figure 39. US & Canada Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Sales Share by Country (2018-2029)
Figure 40. U.S. Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Revenue (2018-2029) & (US$ Million)
Figure 41. Canada Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Revenue (2018-2029) & (US$ Million)
Figure 42. Europe Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Sales Market Share by Type (2018-2029)
Figure 43. Europe Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Revenue Market Share by Type (2018-2029)
Figure 44. Europe Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Sales Market Share by Application (2018-2029)
Figure 45. Europe Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Revenue Market Share by Application (2018-2029)
Figure 46. Europe Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Revenue Share by Country (2018-2029)
Figure 47. Europe Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Sales Share by Country (2018-2029)
Figure 48. Germany Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Revenue (2018-2029) & (US$ Million)
Figure 49. France Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Revenue (2018-2029) & (US$ Million)
Figure 50. UK Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Revenue (2018-2029) & (US$ Million)
Figure 51. Italy Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Revenue (2018-2029) & (US$ Million)
Figure 52. Russia Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Revenue (2018-2029) & (US$ Million)
Figure 53. China Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Sales Market Share by Type (2018-2029)
Figure 54. China Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Revenue Market Share by Type (2018-2029)
Figure 55. China Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Sales Market Share by Application (2018-2029)
Figure 56. China Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Revenue Market Share by Application (2018-2029)
Figure 57. Asia Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Sales Market Share by Type (2018-2029)
Figure 58. Asia Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Revenue Market Share by Type (2018-2029)
Figure 59. Asia Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Sales Market Share by Application (2018-2029)
Figure 60. Asia Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Revenue Market Share by Application (2018-2029)
Figure 61. Asia Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Revenue Share by Region (2018-2029)
Figure 62. Asia Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Sales Share by Region (2018-2029)
Figure 63. Japan Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Revenue (2018-2029) & (US$ Million)
Figure 64. South Korea Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Revenue (2018-2029) & (US$ Million)
Figure 65. China Taiwan Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Revenue (2018-2029) & (US$ Million)
Figure 66. Southeast Asia Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Revenue (2018-2029) & (US$ Million)
Figure 67. India Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Revenue (2018-2029) & (US$ Million)
Figure 68. Middle East, Africa and Latin America Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Sales Market Share by Type (2018-2029)
Figure 69. Middle East, Africa and Latin America Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Revenue Market Share by Type (2018-2029)
Figure 70. Middle East, Africa and Latin America Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Sales Market Share by Application (2018-2029)
Figure 71. Middle East, Africa and Latin America Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Revenue Market Share by Application (2018-2029)
Figure 72. Middle East, Africa and Latin America Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Revenue Share by Country (2018-2029)
Figure 73. Middle East, Africa and Latin America Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Sales Share by Country (2018-2029)
Figure 74. Brazil Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Revenue (2018-2029) & (US$ Million)
Figure 75. Mexico Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Revenue (2018-2029) & (US$ Million)
Figure 76. Turkey Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Revenue (2018-2029) & (US$ Million)
Figure 77. Israel Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Revenue (2018-2029) & (US$ Million)
Figure 78. GCC Countries Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Revenue (2018-2029) & (US$ Million)
Figure 79. Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Value Chain
Figure 80. Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Production Process
Figure 81. Channels of Distribution
Figure 82. Distributors Profiles
Figure 83. Bottom-up and Top-down Approaches for This Report
Figure 84. Data Triangulation
Figure 85. Key Executives Interviewed